Guggenheim Capital LLC Pacira Bio Sciences, Inc. Transaction History

Guggenheim Capital LLC

$13.9 Billion
Q2 2024

A detailed history of Guggenheim Capital LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Guggenheim Capital LLC holds 16,855 shares of PCRX stock, worth $253,836. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,855

Holding current value

$253,836

% of portfolio

0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$25.5 - $31.51 $429,802 - $531,101	16,855 New	16,855 $482,000
Q2 2023 Aug 11, 2023	BUY	$36.12 - $47.5 $144 - $190	4 Added 0.01%	47,229 $1.89 Million
Q1 2023 May 10, 2023	SELL	$35.53 - $43.38 $61,964 - $75,654	-1,744 Reduced 3.56%	47,225 $1.93 Million
Q4 2022 Feb 14, 2023	BUY	$38.19 - $57.45 $1.87 Million - $2.81 Million	48,969 New	48,969 $1.89 Million
Q2 2022 Aug 15, 2022	SELL	$51.49 - $81.64 $3.39 Million - $5.37 Million	-65,765 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$60.03 - $76.49 $78,339 - $99,819	1,305 Added 2.02%	65,765 $5.02 Million
Q4 2021 Feb 14, 2022	SELL	$47.97 - $62.21 $1.31 Million - $1.71 Million	-27,408 Reduced 29.83%	64,460 $3.88 Million
Q3 2021 Nov 15, 2021	SELL	$54.64 - $61.3 $135,616 - $152,146	-2,482 Reduced 2.63%	91,868 $5.15 Million
Q2 2021 Aug 13, 2021	BUY	$59.18 - $69.99 $3.8 Million - $4.5 Million	64,284 Added 213.81%	94,350 $5.73 Million
Q1 2021 May 13, 2021	SELL	$59.31 - $78.82 $548,202 - $728,533	-9,243 Reduced 23.51%	30,066 $2.11 Million
Q4 2020 Feb 16, 2021	BUY	$50.47 - $66.26 $1.98 Million - $2.6 Million	39,309 New	39,309 $2.35 Million
Q4 2018 Feb 14, 2019	SELL	$41.31 - $52.16 $2.16 Million - $2.73 Million	-52,296 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$32.85 - $52.0 $293,974 - $465,348	-8,949 Reduced 14.61%	52,296 $2.57 Million
Q2 2018 Aug 14, 2018	SELL	$27.5 - $39.8 $205,177 - $296,947	-7,461 Reduced 10.86%	61,245 $1.96 Million
Q1 2018 May 15, 2018	BUY	$29.98 - $46.35 $363,117 - $561,391	12,112 Added 21.4%	68,706 $2.14 Million
Q4 2017 Feb 14, 2018	SELL	$31.85 - $46.95 $717,516 - $1.06 Million	-22,528 Reduced 28.47%	56,594 $2.58 Million
Q3 2017 Nov 14, 2017	BUY	$35.7 - $39.5 $2.82 Million - $3.13 Million	79,122	79,122 $2.97 Million

Others Institutions Holding PCRX

# of Institutions

302

Shares Held

51.5M

Call Options Held

378K

Put Options Held

1.53M

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $690M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Pacira Bio Sciences, Inc. Transaction History